MEDNAX (MD) Misses Q3 EPS by 2c, Guides Q4 EPS Below the Street

October 27, 2016 7:26 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

MEDNAX (NYSE: MD) reported Q3 EPS of $1.09, $0.02 worse than the analyst estimate of $1.11. Revenue for the quarter came in at $828 million versus the consensus estimate of $821.18 million.


MEDNAX sees Q4 2016 EPS of $1.04-$1.08, versus the consensus of $1.13.

For earnings history and earnings-related data on MEDNAX (MD) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment